Back

Hemodynamic forces from 4D flow magnetic resonance imaging for optimised prediction of cardiac resynchronisation therapy outcome

27 August 2023 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Exploring heart morphology and function with cutting-edge cardiac MRI technology Flow Imaging ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Karin Pola

Skane University Hospital, Lund (Sweden)

7 More presentations in this session

Presentation thumbnail
Ventricular volume ratio as a novel imaging biomarker for disease prediction in 26,516 UK Biobank participants
Ms C. McCracken (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Diabetic atrial cardiomyopathy can be identified by multiparametric mri MRI associating atrio-ventricular groove adipose tissue and left atrial strain profiles
Professor S. Hatem (Paris, FR)
Abstract Slides Video
Presentation thumbnail
The effect of atrial morphology on atrial function in hypertrophic cardiomyopathy
Mr J. Weerts (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Liver fibrosis is associated with left ventricular remodeling: insights into the liver-heart axis
Mr C. Edin (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Spin-lock based magnetic field sensing: a non-invasive MRI method for spatially resolved imaging of cardiac conduction?
Ms P. Albertova (Wurzburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring heart morphology and function with cutting-edge cardiac MRI technology

The Event

Event poster

ESC Congress 2023

27 August 2023 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of echocardiography-derived hemodynamic force parameters with left ventricular reverse remodeling after cardiac resynchronization in non-ischemic cardiomyopathy
thumbnail
Congress Presentation
Heart failure and reduced ejection fraction: the bread and butter of cardiovascular imaging - discussion
thumbnail
Congress Presentation
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources